# Evaluation of Prolonged Asparaginase Activity Levels After Calaspargase Pegol Administration

> **NCT07221656** · — · NOT_YET_RECRUITING · sponsor: **Mayo Clinic** · enrollment: 20 (estimated)

## Conditions studied

- Childhood Acute Lymphoblastic Leukemia
- Childhood Lymphoblastic Lymphoma

## Interventions

- **OTHER:** Non-Interventional Study

## Key facts

- **NCT ID:** NCT07221656
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2027-02-01
- **Primary completion:** 2028-12-31
- **Final completion:** 2028-12-31
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2026-04-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07221656

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07221656, "Evaluation of Prolonged Asparaginase Activity Levels After Calaspargase Pegol Administration". Retrieved via AI Analytics 2026-06-11 from https://api.ai-analytics.org/clinical/NCT07221656. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*